Summary by Futu AI
Robert Hershberg, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock transaction on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following the transaction, Hershberg's direct holdings in the company increased to a total of 51,716 shares. The grant is part of the company's compensation strategy and reflects the ongoing commitment to align the interests of its executives with those of shareholders.